• Je něco špatně v tomto záznamu ?

Digital Screen Time and the Risk of Female Breast Cancer: A Retrospective Matched Case-Control Study

SAR. Mortazavi, S. Tahmasebi, JC. Lech, JS. Welsh, A. Taleie, A. Rezaianzadeh, A. Zamani, K. Mega, S. Nematollahi, A. Zamani, SMJ. Mortazavi, L. Sihver

. 2024 ; 14 (2) : 169-182. [pub] 20240401

Status neindexováno Jazyk angličtina Země Írán

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013084

Grantová podpora
001 World Health Organization - International

BACKGROUND: As the use of electronic devices such as mobile phones, tablets, and computers continues to rise globally, concerns have been raised about their potential impact on human health. Exposure to high energy visible (HEV) blue light, emitted from digital screens, particularly the so-called artificial light at night (ALAN), has been associated with adverse health effects, ranging from disruption of circadian rhythms to cancer. Breast cancer incidence rates are also increasing worldwide. OBJECTIVE: This study aimed at finding a correlation between breast cancer and exposure to blue light from mobile phone. MATERIAL AND METHODS: In this retrospective matched case-control study, we aimed to investigate whether exposure to blue light from mobile phone screens is associated with an increased risk of female breast cancer. We interviewed 301 breast cancer patients (cases) and 294 controls using a standard questionnaire and performed multivariate analysis, chi-square, and Fisher's exact tests for data analysis. RESULTS: Although heavy users in the case group of our study had a statistically significant higher mean 10-year cumulative exposure to digital screens compared to the control group (7089±14985 vs 4052±12515 hours, respectively, P=0.038), our study did not find a strong relationship between exposure to HEV and development of breast cancer. CONCLUSION: Our findings suggest that heavy exposure to HEV blue light emitted from mobile phone screens at night might constitute a risk factor for promoting the development of breast cancer, but further large-scale cohort studies are warranted.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013084
003      
CZ-PrNML
005      
20240726151521.0
007      
ta
008      
240723s2024 ir f 000 0|eng||
009      
AR
024    7_
$a 10.31661/jbpe.v0i0.2310-1678 $2 doi
035    __
$a (PubMed)38628888
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ir
100    1_
$a Mortazavi, Seyed Ali Reza $u College of Medical, Veterinary & Life Sciences, University of Glascow, Glasgow, GB
245    10
$a Digital Screen Time and the Risk of Female Breast Cancer: A Retrospective Matched Case-Control Study / $c SAR. Mortazavi, S. Tahmasebi, JC. Lech, JS. Welsh, A. Taleie, A. Rezaianzadeh, A. Zamani, K. Mega, S. Nematollahi, A. Zamani, SMJ. Mortazavi, L. Sihver
520    9_
$a BACKGROUND: As the use of electronic devices such as mobile phones, tablets, and computers continues to rise globally, concerns have been raised about their potential impact on human health. Exposure to high energy visible (HEV) blue light, emitted from digital screens, particularly the so-called artificial light at night (ALAN), has been associated with adverse health effects, ranging from disruption of circadian rhythms to cancer. Breast cancer incidence rates are also increasing worldwide. OBJECTIVE: This study aimed at finding a correlation between breast cancer and exposure to blue light from mobile phone. MATERIAL AND METHODS: In this retrospective matched case-control study, we aimed to investigate whether exposure to blue light from mobile phone screens is associated with an increased risk of female breast cancer. We interviewed 301 breast cancer patients (cases) and 294 controls using a standard questionnaire and performed multivariate analysis, chi-square, and Fisher's exact tests for data analysis. RESULTS: Although heavy users in the case group of our study had a statistically significant higher mean 10-year cumulative exposure to digital screens compared to the control group (7089±14985 vs 4052±12515 hours, respectively, P=0.038), our study did not find a strong relationship between exposure to HEV and development of breast cancer. CONCLUSION: Our findings suggest that heavy exposure to HEV blue light emitted from mobile phone screens at night might constitute a risk factor for promoting the development of breast cancer, but further large-scale cohort studies are warranted.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tahmasebi, Sedigheh $u Breast Cancer Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
700    1_
$a Lech, James C $u Department of Radiology and Nuclear Medicine, Academic Medical Center, University of Amsterdam (UMC), Amsterdam, The Netherlands $u International EMF Project & Optical Radiation, World Health Organization, Pretoria, South Africa
700    1_
$a Welsh, James S $u Department of Radiation Oncology, Stritch School of Medicine Loyola University Chicago, Maywood, IL, USA $u Department of Radiation Oncology, Edward Hines Jr Veterans Affairs Hospital, Maywood, Illinois, USA
700    1_
$a Taleie, Abdorasoul $u School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
700    1_
$a Rezaianzadeh, Abbas $u School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
700    1_
$a Zamani, Ali $u Department of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
700    1_
$a Mega, Kanu $u School of Life Sciences, Manipal Academy of Higher Education, Dubai International Academic City, Dubai, UA
700    1_
$a Nematollahi, Samaneh $u Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran
700    1_
$a Zamani, Atefeh $u School of Mathematics and Statistics, University of New South Wales, Sydney, New South Wales, Australia
700    1_
$a Mortazavi, Seyed Mohammad Javad $u Ionizing and Non-ionizing Radiation Protection Research Center (INIRPRC), Shiraz University of Medical Sciences, Shiraz, Iran
700    1_
$a Sihver, Lembit $u Department of Radiation Physics, Atominstitut, Technische Universität Wien, Vienna, Austria $u Department of Radiation Dosimetry, Nuclear Physics Institute of the Czech Academy of Sciences, Prague, Czech Republic
773    0_
$w MED00215026 $t Journal of biomedical physics & engineering $x 2251-7200 $g Roč. 14, č. 2 (2024), s. 169-182
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38628888 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240723 $b ABA008
991    __
$a 20240726151514 $b ABA008
999    __
$a ok $b bmc $g 2125597 $s 1224947
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 14 $c 2 $d 169-182 $e 20240401 $i 2251-7200 $m Journal of biomedical physics & engineering $n J Biomed Phys Eng $x MED00215026
GRA    __
$a 001 $p World Health Organization $2 International
LZP    __
$a Pubmed-20240723

Najít záznam

Citační ukazatele

Možnosti archivace